Sign in

CIK 0001604821

  • Large accelerated filer

Natera, Inc.

Sign in to watch
Ticker
NTRA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
010894487
Phone
+1 650-249-9090
Business address
13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
Former names
Natera, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$104,832,418
in 28 filings, $104.8M under 10b5-1 plans

Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-04-23 Brophy Michael Burkes CHIEF FINANCIAL OFFICER Sale 10b5-1 −1,523 $91.38 $139K 73,039
2024-04-22 Brophy Michael Burkes CHIEF FINANCIAL OFFICER Exercise or conversion 10b5-1 +1,250 74,562
2024-04-22 Brophy Michael Burkes CHIEF FINANCIAL OFFICER Exercise or conversion · Restricted Stock Unit 10b5-1 −1,250 7,500
2024-04-21 Sheena Jonathan Director Exercise or conversion 10b5-1 +143 321,364
2024-04-21 Sheena Jonathan Director Exercise or conversion · Restricted Stock Unit 10b5-1 −143 430
2024-04-21 RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Exercise or conversion 10b5-1 +644 206,339
2024-04-21 RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Exercise or conversion · Restricted Stock Unit 10b5-1 −644 1,932
2024-04-21 Chapman Steven Leonard CEO AND PRESIDENT Exercise or conversion 10b5-1 +1,775 232,871
2024-04-21 Chapman Steven Leonard CEO AND PRESIDENT Exercise or conversion · Restricted Stock Unit 10b5-1 −1,775 5,324
2024-04-21 Brophy Michael Burkes CHIEF FINANCIAL OFFICER Exercise or conversion 10b5-1 +1,145 73,312
2024-04-21 Brophy Michael Burkes CHIEF FINANCIAL OFFICER Exercise or conversion · Restricted Stock Unit 10b5-1 −1,145 3,435
2024-04-20 Sheena Jonathan Director Exercise or conversion 10b5-1 +190 321,221
2024-04-20 Sheena Jonathan Director Exercise or conversion · Restricted Stock Unit 10b5-1 −190 1,332
2024-04-20 RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Exercise or conversion 10b5-1 +856 205,695
2024-04-20 RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Exercise or conversion · Restricted Stock Unit 10b5-1 −856 5,992
2024-04-20 Chapman Steven Leonard CEO AND PRESIDENT Exercise or conversion 10b5-1 +3,386 231,096
2024-04-20 Chapman Steven Leonard CEO AND PRESIDENT Exercise or conversion · Restricted Stock Unit 10b5-1 −3,386 23,702
2024-04-20 Brophy Michael Burkes CHIEF FINANCIAL OFFICER Exercise or conversion 10b5-1 +1,521 72,167
2024-04-20 Brophy Michael Burkes CHIEF FINANCIAL OFFICER Exercise or conversion · Restricted Stock Unit 10b5-1 −1,521 10,653
2024-04-16 Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Sale 10b5-1 −26,511 $90.34 $2.4M 171,049

Page 74 of 85 · 1,682 trades